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Background: In humans, trophoblast invasion, vascular remodeling and placental development are critical to
determine the fate of pregnancy. Since guinea-pigs (GP) and humans share common pregnancy features including
extensive trophoblast invasion, transformation of the uterine spiral arteries and a haemomonochorial placenta, the
GP animal model was deemed suitable to extend our knowledge on the spatio-temporal immunoreactive
expression of the vasodilator arpeptide of the renin-angiotensin system, angiotensin-(1–7) [Ang-(1–7)] and its main
generating enzyme, angiotensin converting enzyme 2 (ACE2).
Methods: Utero-placental units were collected in days 15, 20, 40 and 60 of a 64–67 day long pregnancy in 25
Pirbright GP. Ang-(1–7) and ACE2 expression in utero-placental units were evaluated by immunohistochemistry.
Results: Ang-(1–7) and ACE2 were detected in the endothelium and syncytiotrophoblast of the labyrinthine
placenta, interlobium, subplacenta, giant cells, syncytial sprouts, syncytial streamers, and myometrium throughout
pregnancy. In late pregnancy, perivascular or intramural trophoblasts in spiral and mesometrial arteries expressed
both factors. Immunoreactive Ang-(1–7) and ACE2 were present in decidua and in the vascular smooth muscle of
spiral, myometrial and mesometrial arteries, which also express kallikrein (Kal), the bradykinin receptor 2 (B2R),
vascular endothelial growth factor (VEGF) and its type 2 receptor (KDR), but no endothelial nitric oxide synthase
(eNOS). In addition, the signal of Ang-(1–7) and ACE2 was especially remarkable in giant cells, which also show Kal,
B2R. eNOS, VEGF and KDR.
Conclusions: The spatio-temporal expression of Ang-(1–7) and ACE2 in GP, similar to that of humans, supports a
relevant evolutionary conserved function of Ang-(1–7) and ACE2 in decidualization, trophoblast invasion, vascular
remodeling and placental flow regulation, as well as the validity of the GP model to understand the local
adaptations of pregnancy. It also integrates Ang-(1–7) to the utero-placental vasodilatory network. However, its
antiangiogenic effect may counterbalance the proangiogenic activity of some of the other vasodilator components.Background
The outcome of pregnancy depends upon the success of
placentation. In normal human pregnancy, extravillous
trophoblasts (EVT) after anchoring in the uterine wall
migrate through the decidualized stroma to invade the
uterine spiral arteries. This last process destroys vascular
smooth muscle and replaces the endothelium with EVT
by the second trimester of pregnancy. This remodeling
increases vessel diameter and creates a high flow, low
resistance arteriolar system that meets the increased* Correspondence: gvaldesst@gmail.com
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reproduction in any medium, provided the ordemands of the fetus across the barrier of the rich de
novo vasculature of the placenta. The disturbance of this
finely tuned orchestrated sequence causes important
obstetric and neonatal complications that range from
miscarriages due to failed attachment to the extensive
invasion of placenta accreta. In the midst, a shallow
invasion results in intrauterine growth retardation, or in
a hypoperfused placenta which sheds to the maternal
circulation microvillous particles and soluble factors that
cause the clinical phase of preeclampsia. Among these
factors, agonistic autoantibodies to angiotensin II recep-
tor 1 (AT1-AA) participate in the physiopathology of
preeclampsia, stressing the prominence of the renin-
angiotensin system (RAS) in this condition [1,2].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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In normal human pregnancy the vasoconstrictor peptide
angiotensin II (Ang II) is elevated [3], but the counter-
balancing vasodilator angiotensin-(1–7) [Ang-(1–7)] is
increased in plasma and urine [4,5]. Angiotensin-
converting enzyme 2 (ACE2), a pleiotropic monocarbox-
ypeptidase [6], is the main Ang-(1–7) generating enzyme
and influences the relative expression/functions of Ang
II and Ang-(1–7). Ang-(1–7) most likely contributes to
the reduction in the systemic vascular resistance and the
maintenance of normal systemic blood pressure, as sug-
gested by its defective response in preeclampsia [4] and
by the increment of blood pressure in pregnant ACE2
knock-out mice [7]. Apart from vasoactive effects, Ang
II stimulates proliferation and angiogenesis [8,9], while
Ang-(1–7) is antiproliferative and antiangiogenic [10].
In human utero-placental tissues the traditional vaso-
constrictor components of the RAS are ubiquitous
[11-16]. As to vasodilator peptides and receptors of the
RAS, Broughton-Pipkin and her group have recently
shown higher early expression of the receptor of Ang IV
in the syncytiotrophoblast and extravillous trophoblast
[12]; in addition, our laboratories have shown that Ang-
(1–7) and ACE2 are expressed in multiple sites of the
utero-placental interface [17,18].
Since vasodilators are key players in the hemodynamic
local adaptations of pregnancy, we now aim at under-
standing the paracrine role of Ang-(1–7) and ACE2 in the
utero-placental unit by evaluating the immunohistochem-
ical expression of both factors in the guinea-pig. This
caviomorph rodent shares with women: (a) a haemomo-
nochorial placenta; (b) similar progesterone levels and
response to progesterone antagonists [19]; (c) an extensive
trophoblast invasion and remodeling of the utero-
placental arteries [20,21]; (d) the expression of paracrine
factors implicated in vasodilation and trophoblast inva-
sion, as matrix metalloproteases (MMPs), kallikrein (Kal),
bradykinin 2 receptor (B2R), endothelial nitric oxide syn-
thase (eNOS), vascular endothelial growth factor (VEGF),
VEGFR-2 (Flk-1/KDR) and VEGFR-1 (Flt-1) [22,23]; (e)
pregnancy toxemia, observed in animals with spontaneous
aortic stenosis below the renal arteries or with banded
uterine arteries and transected ovarian arteries [24,25].
Accruing further information on the presence and
localization of vasodilator components within the RAS in
this species will help understand their participation in the
local adaptations of human pregnancy.
Methods
Guinea-pigs (Pirbright white Cavia porcellus ~600 g) were
housed under controlled humidity, temperature and light
cycle conditions. Females were examined daily, and were
caged with fertile males when perforation of the vaginal
closure membrane ocurred; the day a copulatory plug wasobserved was defined as day one of pregnancy. Twenty-
five dams were sacrificed in early to term pregnancy, on
days 15 (n = 4), 20 (n = 6), 40 (n = 7), and 60 (n = 8) of a
64–67 day pregnancy, after being anesthetized with an
intraperitoneal injection of ketamine (100 mg/kg) and
xylazine (4 mg/kg). The uterus was dissected and feto-
placental units (2–5 per dam) were removed; some were
sagitally sliced and fixed in a single block, in others the
placenta, endometrium, and mesometrium were sepa-
rated. The animals were euthanized with an overdose
of anesthesia. Tissues were fixed immediately with
phosphate-buffered 4% formalin for 24 hours.
Ethical approval
The experiments were conducted according to the Guide
for the Care and Use of Laboratory Animals (National
Research Council, USA) and approved by the Ethics Com-
mittee of FONDECYT (Fondo Nacional de Desarrollo
Científico y Tecnológico, Chile).
Immunohistochemistry
Fixed tissues were paraffin embedded, sectioned (5 μm),
dehydrated in a graded series of ethanol and xylene and
included in Paraplast-PlusW (Sigma, St. Louis, MO). Sections
were deparaffinized in xylene and rehydrated in a graded
alcohol series. Endogenous peroxidases were blocked with
incubation in 10% H2O2 for 10 minutes. Sections were incu-
bated in a humid chamber for 30 minutes with goat serum
(Vector Laboratories, Burlingame, CA) as a protein block
followed by incubation for 18 hours at 4°C with the primary
antibodies. These antibodies were affinity-purified polyclonal
rabbit anti-Ang-(1–7) (1:25) and anti-ACE2 (1:1000) pro-
duced by our group at Wake Forest School of Medicine
[18,26]. Sections were immunostained using a biotin-
streptavidin-peroxidase system (LSAB+W, DakoCytomation,
Carpinteria, CA). Finally, the samples were treated for 15
minutes with 0.1% (w/v) 3-3'-diaminobenzidine (Sigma) in
buffer containing 0.05% H2O2. The slides were counter-
stained with Harris hematoxylin (Sigma).
Cytotrophoblasts were identified by staining with an
antipancytokeratin mouse monoclonal antibody (1:100,
P2871, Sigma). Smooth muscle and endothelial cells
were characterized with antibodies against α-smooth
muscle actin (1A4, 1:1500) and von Willebrand factor
(A0082, 1:400) respectively, both from DakoCytomation,
Carpinteria, CA. The specificity of the staining was deter-
mined by eliminating the primary antibody, incubating
with non-specific immunoglobulin or by preadsorbing
with the peptide to which the antibody was generated.
Previous studies which were revised in the context of
the present work [22,23] were performed with the
following antibodies: rabbit polyclonal antiserum against
purified rat urinary kallikrein (1:2000), mouse monoclo-
nal anti-eNOS (1:50, BD Transduction Laboratories,
AB
Figure 1 Ang-(1–7) immunoreactivity in different stages and
structures of the utero-placental unit. This expression
(orange-brown) is depicted in giant cells (GC), syncytial streamers (S),
labyrinth (LAB) and vascular smooth muscle (VSM) in myometrial
artery of gestational days (G) 14, 20, 40 and 60 of the pregnant
guinea-pig. (B) ACE2 immunoreactivity in different stages and
structures of the utero-placental unit. This expression
(orange-brown) is depicted in giant cells, syncytial streamers and
vascular smooth muscle of myometrial artery of gestational days (G)
15, 20, 40 and 60 of the pregnant guinea-pig. (x400).
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Syracuse, NY) and rabbit polyclonal KDR (1:500, Up-
state). The B2R antibody (1:4000), kindly donated by Dr.
Werner Müller-Esterl, Frankfurt Universitäts, Germany,
was raised against the rat kinin B2R and recognizes the
various domains of the receptor.
Results
In embryonic derived cells immunoreactivity for Ang-
(1–7) (Figure 1A) and ACE2 (Figure 1B) was detected in
the interlobium, endothelium and syncytiotrophoblast of
the labyrinthine placenta, subplacenta, giant cells, syn-
cytial sprouts, syncytial streamers and intravascular and
intraluminal trophoblasts (Table 1).
In maternal tissues, decidua, vascular smooth muscle
and endothelial cells of spiral and mesometrial arteries,
as well as the myometrium, showed Ang-(1–7) and
ACE2 (Figures 1 and 2, Table 1). The decidual expres-
sion of ACE2 was stronger in gestational days 15 and 20
as compared to day 40. In late gestation (day 60), the
necrotic areas in the subplacenta, decidual cells, and
streamers hindered the observation of the expression of
Ang-(1–7) and ACE2 in these zones.
The signal for both Ang-(1–7) and ACE2 was espe-
cially remarkable in the markedly protrusive parietal
giant cells that envelop the maternal blood sinuses with
long cytoplasmic laminas (Figures 1 and 2).
Ang-(1–7) and ACE2 expression was coarsely granular
in giant cells and vascular smooth muscle, finely granu-
lar in the labyrinth, interlobium and decidual cells, and
diffuse with a peripheral reinforcement in syncytial
streamers.
Temporal assessment showed that Ang-(1–7) and
ACE2 were expressed throughout pregnancy in the giant
cells, labyrinth and myometrial arteries. As early as day
15 of gestation, invasive trophoblasts coalesced into
synctyial streamers and migrated into the endometrium;
their immunoreactive expression of Ang-(1–7) and
ACE2 was more intense in early and mid pregnancy as
compared to late pregnancy, when streamers were
diminished. In the myometrium, spiral arteries were sur-
rounded by Ang-(1–7) and ACE2 positive trophoblasts.
In days 40 and 60 of late gestation, uterine and mesome-
trial arteries were multilayered, and displayed Ang-(1–7)
and ACE2 in vascular smooth muscle and invading
trophoblasts.
Control sections incubated with non-specific immuno-
globulin or in the absence of the first antibody yielded
no staining in different structures and stages of preg-
nancy (not shown). Sections preincubated with an excess
of peptide that corresponds to the epitope recognized by
the antibody showed no immunoreactive signal for Ang-
(1–7), while for ACE2 some background staining
persisted (Figure 2).
Table 1 Distribution of Angiotensin-(1–7) and ACE2 in the guinea-pig utero-placental unit in early (day 15), mid (days 20 and 40) and late (day 60) gestation
Day of Gestation Giant cells Interlobium Labyrinth Subplacenta Decidual cells Streamers Spiral arteries SM spiral arteries Myometrium Mesometrium
Ang-(1–7)
Day 15 + + Not recognizable ± + + VSM + + VSM
Day 20 + + + + + VSM + + VSM
Day 40 + SCT, endothelium SCT, endothelium + + + VSM + + VSM
Day 60 + + + Necrotic Necrotic Necrotic VSM, IVTB + + VSM, endothelium
ACE2
Day 15 + + Not recognizable ± + + VSM + + VSM
Day 20 + + + + + + VSM + + VSM
Day 40 + SCT, endothelium SCT, endothelium + ± ± VSM + + VSM
Day 60 + SCT, endothelium SCT, endothelium Necrotic Necrotic Necrotic VSM, IVTB VSM, IVTB + VSM, endothelium
SCT = syncytiotrophoblast; IVTB =intravascular trophoblast; VSM = smooth muscle. Necrotic areas in late gestation in the central portion of the utero-placental unit were identified by the disruption of the tissues.

















Figure 2 Immunoreactive expression of Ang-(1–7) and ACE2 in
giant cells (GC) and labyrinth (LAB), from a gestational day 60
pregnant guinea-pig. Sections were preincubated with and
without the immunizing peptide. (x400).
Figure 3 Sequential sections of the myometrial artery in gestational d
Ang-(1–7) and ACE2. These show a moderate signal for kallikrein (Kal), a f
growth factor (VEGF) and its type 2 receptor (KDR), and no endothelial nitr
characterized by α-smooth muscle actin. These vasodilators are present in
of cytokeratin (CK) positive cells demonstrates no intraarterial extravillous tr
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The spatio-temporal expression of Ang-(1–7) and ACE2
in sites related to decidualization, trophoblast invasion,
vascular remodeling, placental flow regulation and plate-
let antiaggregation supports a relevant role of these
peptides/proteins in the gestation of the guinea-pig.
The coincident location of Ang-(1–7) and ACE2 in
the guinea-pig and in equivalent human structures as
reported by Pringle et al. [11] and by us [18] endorses
an evolutionary conserved role, and provides further
confirmation of the validity of the guinea-pig model to
understand human pregnancy. The shift of the pre-
dominance of Ang II in the uterine fundus to Ang-(1–7)
in the placental bed [18] and the increased expression
of Ang-(1–7) and ACE2 mRNA in early pregnancy
as compared to normal term pregnancy [17 are indica-
tive of an early vasodilatory effect on the maternal
vasculature.
Rats, as guinea-pigs, express Ang-(1–7) and ACE2 stain-
ing in the labyrinthine placenta [26]. The marked decrement
of placental and uterine Ang-(1–7) concentrations in the
reduced uterine perfusion pressure rat model of hyperten-
sive pregnancy [26] supports a role of this vasodilator in
normotensive pregnancy.
The localization of Ang-(1–7) in the same cell types that
express other vasodilator factors in this species (Kal, the
B2R, eNOS, VEGF and KDR) [22,23] highlights the import-
ance and complexity of the utero-placental vasodilator
network [27]. As in women, Ang-(1–7) and ACE2 in the
guinea pig are additionally expressed in decidual cells. The
vascular smooth muscle of myometrial and mesometrialay 40, which in Figure 1A and B displays immunoreactivity for
aint and scanty one for bradykinin R2 (B2R), vascular endothelial
ic oxide synthase (eNOS), in vascular smooth muscle (VSM)
endothelial cells characterized by von Willebrand factor (vWF). Absence
ophoblasts. (x200).
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and ACE2, a moderate signal for kallikrein, a faint signal in
scant cells for B2R, VEGF and KDR and absence of eNOS
(Figure 3). This localization of the paracrine/autocrine vaso-
dilator components of the RAS in both maternal and fetal
components of the utero-placental unit, suggests their
instrumental participation in trophoblast invasion and spiral
artery remodeling. The preparation of arteries for tropho-
blast invasion has been mainly attributed to the nearby
trophoblasts, uterine natural killer cells and macrophages. In
this case, it is feasible that Ang-(1–7) generated by the
vascular smooth muscle interacts with NO liberated by its
“pacemaker”, the approaching trophoblast [28]. The rele-
vance of uterine artery vasodilatation in pregnancy has been
underscored in the ewe, by the demonstration that even
vasoconstrictor Ang II induces in them PGI2 and NO endo-
thelial production [29].
The intense expression of Ang-(1–7) and ACE2 in
giant cells observed in this study made us re-assess in
them our previous analysis on the immunoreactive
expression of the vasodilator panel in the guinea pig
[22,23]. In sequential sections we found a strong immu-
noreactive signal for VEGF and a moderate signal for
kallikrein, the B2R, eNOS, and KDR (Figure 4). In future
studies the prominence of Ang-(1–7) and ACE in par-
ietal giant cells needs to be examined in regard to their
functional importance in decidualization, trophoblast
invasion, synthesis of a wide range of hormones, angio-
genic and vasodilatory factors (VEGF, NO) and glycogen
and glycoproteins storage [28,30]. If their hormonal
production is disturbed, vascularization of the decidua is
compromised, and embryos present lethal defects. In
mice, inhibition or overabundance of giant cells are
equally detrimental.Figure 4 Giant cell (GC) expression of vasodilator factors. The signal i
for its type 2 receptor (KDR), kallikrein (Kal), the bradykinin B2 receptor
different sets of sequential sections (upper and lower panels). Asterisk
interlobium=IL. (x400).In contrast to VEGF, NO, bradykinin and Ang II, plei-
tropic Ang-(1–7) is a potent antiagiogenic factor, which
impairs tube formation by human umbilical cells [31],
growth of tumors and tumoral cells and vascularization
of sponge implants [32-34]. The importance of ACE2 in
mediating the Ang II-Ang-(1–7) balance is supported by
growth of pancreatic cancer cells when its mRNA is
silenced and by inhibition of tumor expansion when the
enzyme is overexpressed [35].
The localization of Ang-(1–7) and ACE2 in different
structures of the guinea-pig utero-placental unit tallies
with a role of these factors in the regulation of tropho-
blast invasion, angiogenesis and blood flow. The findings
described herein show that the guinea-pig represents an
attractive model to manipulate the opposing arms of the
RAS in order to understand the functionality of the sys-
tem in the systemic and local adaptations of pregnancy.
Adding a new species to the mice and rat models now in
use will especially contribute to the study of the placental
bed along pregnancy, since this crucial territory is out-of-
bounds for research in ongoing human pregnancies.Conclusions
The spatio-temporal expression of Ang-(1–7) and ACE2
in GP, similar to that of humans, supports a relevant
evolutionary conserved function of Ang-(1–7) and ACE2
in decidualization, trophoblast invasion, vascular remod-
eling and placental flow regulation, as well as the validity
of the GP model to understand the local adaptations
of pregnancy. It also integrates Ang-(1–7) to the utero-
placental vasodilatory network. However, its antiangio-
genic effect may counterbalance the proangiogenic
activity of some of the other vasodilatory components.s intense for vascular endothelial growth factor (VEGF), moderate
(B2R) and endothelial nitric oxide synthase (eNOS) in two
s indicate the same cell in each panel. Visceral yolk sac=VYS,
Valdés et al. Reproductive Biology and Endocrinology 2013, 11:5 Page 7 of 8
http://www.rbej.com/content/11/1/5Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The study was conceived by GV and KBB; the design, the histological
analysis, the interpretation of the data and the drafting of the manuscript
were done by GV and JC; JC sacrificed the animals and prepared the tissue
sections; she and DS performed the immunohistochemistry of non-RAS
factors; MSB and JJ performed the inmmunohistochemistry for Ang-(1–7)
and ACE2; KBB participated in the analysis of the data and in the different
versions of the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported in part by FONDECYT grants (1080228 and
1121161) and P01-NHLBI-51952. The authors gratefully acknowledge support
in part by Unifi, Greensboro, NC, Farley-Hudson Foundation, Jacksonville, NC,
and by two Chilean private donations.
Author details
1Centro de Investigaciones Médicas y Departamento de Nefrología, Escuela
de Medicina, Pontificia Universidad Católica, Santiago, Chile. 2Hypertension
and Vascular Research Center, Wake Forest School of Medicine,
Winston-Salem, NC, USA.
Received: 7 September 2012 Accepted: 14 January 2013
Published: 22 January 2013
References
1. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur
E, Nissen E, Vetter K, Neichel D, et al: Patients with preeclampsia develop
agonistic autoantibodies against the angiotensin AT1 receptor. J Clin
Invest 1999, 103:945–952.
2. Xia Y, Ramin SM, Kellems RE: Potential roles of angiotensin
receptor-activating autoantibody in the pathophysiology of
preeclampsia. Hypertension 2007, 50:269–275.
3. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon
P, Papera S, Sealey JE, Laragh JH: Blood pressure, the renin-aldosterone
system and sex steroids throughout normal pregnancy. Am J Med 1980,
68:97–104.
4. Merrill DC KM, Chen K, Ferrario CM, Brosnihan KB: Angiotensin-(1–7) in
normal and preeclamptic pregnancy. Endocrine 2002, 18:239–245.
5. Valdes G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM,
Brosnihan KB: Urinary vasodilator and vasoconstrictor angiotensins
during menstrual cycle, pregnancy, and lactation. Endocrine 2001,
16:117–122.
6. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-
dos-Santos AJ, da Costa J, Zhang L, Pei Y, et al: Angiotensin-converting
enzyme 2 is an essential regulator of heart function. Nature 2002,
417:822–828.
7. Bharadwaj MS, Strawn WB, Groban L, Yamaleyeva LM, Chappell MC,
Horta C, Atkins K, Firmes L, Gurley SB, Brosnihan KB: Angiotensin-
converting enzyme 2 deficiency is associated with impaired
gestational weight gain and fetal growth restriction.
Hypertension 2011, 58:852–858.
8. Touyz RM, Deng LY, He G, Wu XH, Schiffrin EL: Angiotensin II stimulates
DNA and protein synthesis in vascular smooth muscle cells from human
arteries: role of extracellular signal-regulated kinases. J Hypertens 1999,
17:907–916.
9. Zhang F, Hu Y, Xu Q, Ye S: Different effects of angiotensin II and
angiotensin-(1–7) on vascular smooth muscle cell proliferation and
migration. PLoS One 2010, 5:e12323.
10. Tallant EA, Diz DI, Ferrario CM: State-of-the-Art lecture. Antiproliferative
actions of angiotensin-(1–7) in vascular smooth muscle. Hypertension
1999, 34:950–957.
11. Pringle KG, Tadros MA, Callister RJ, Lumbers ER: The expression and
localization of the human placental prorenin/renin-angiotensin
system throughout pregnancy: roles in trophoblast invasion and
angiogenesis? Placenta 2011, 32:956–962.12. Williams PJ, Mistry HD, Innes BA, Bulmer JN, Broughton Pipkin F:
Expression of AT1R, AT2R and AT4R and their roles in extravillous
trophoblast invasion in the human. Placenta 2012, 31:448–455.
13. Acker GM, Galen FX, Devaux C, Foote S, Papernik E, Pesty A, Menard J,
Corvol P: Human chorionic cells in primary culture: a model for renin
biosynthesis. J Clin Endocrinol Metab 1982, 55:902–909.
14. Hodari AA, Smeby R, Bumpus FM: A renin-like substance in the human
placenta. Obstet Gynecol 1967, 29:313–317.
15. Symonds EM, Stanley MA, Skinner SL: Production of renin by in vitro
cultures of human chorion and uterine muscle. Nature 1968,
217:1152–1153.
16. Shaw KJ, Do YS, Kjos S, Anderson PW, Shinagawa T, Dubeau L, Hsueh WA:
Human decidua is a major source of renin. J Clin Invest 1989,
83:2085–2092.
17. Valdes G, Neves LA, Anton L, Corthorn J, Chacon C, Germain AM, Merrill DC,
Ferrario CM, Sarao R, Penninger J, Brosnihan KB: Distribution of
angiotensin-(1–7) and ACE2 in human placentas of normal and
pathological pregnancies. Placenta 2006, 27:200–207.
18. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K,
Gallagher PE, Moorefield C, Gruver C, Brosnihan KB: The uterine placental
bed renin-angiotensin system in normal and preeclamptic pregnancy.
Endocrinology 2009, 150:4316–4325.
19. Elger W, Bartley J, Schneider B, Kaufmann G, Schubert G, Chwalisz K:
Endocrine pharmacological characterization of progesterone
antagonists and progesterone receptor modulators with respect
to PR-agonistic and antagonistic activity. Steroids 2000, 65:713–723.
20. Nanaev A, Chwalisz K, Frank HG, Kohnen G, Hegele-Hartung C,
Kaufmann P: Physiological dilation of uteroplacental arteries in the
guinea pig depends on nitric oxide synthase activity of
extravillous trophoblast. Cell Tissue Res 1995, 282:407–421.
21. Mess A, Zaki N, Kadyrov M, Korr H, Kaufmann P: Caviomorph placentation
as a model for trophoblast invasion. Placenta 2007, 28:1234–1238.
22. Valdes G, Erices R, Chacón C, Corthorn J: Angiogenic,
hyperpermeability and vasodilator network in utero-placental
units along pregnancy in the guinea-pig (Cavia porcellus). Reprod
Biol Endocrinol 2008, 6:13.
23. Corthorn J, Rey S, Chacon C, Valdes G: Spatio-temporal expression
of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of
the pregnant guinea-pig (Cavia porcellus). Reprod Biol Endocrinol
2007, 5:27.
24. Seidl DC, Hughes HC, Bertolet R, Lang CM: True pregnancy toxemia
(preeclampsia) in the guinea pig (Cavia porcellus). Lab Anim Sci 1979,
29:472–478.
25. Golden JG, Hughes HC, Lang CM: Experimental toxemia in the pregnant
guinea pig (Cavia porcellus). Lab Anim Sci 1980, 30:174–179.
26. Neves LA, Stovall K, Joyner J, Valdes G, Gallagher PE, Ferrario CM,
Merrill DC, Brosnihan KB: ACE2 and ANG-(1–7) in the rat uterus
during early and late gestation. Am J Physiol Regul Integr Comp
Physiol 2008, 294:R151–R161.
27. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-
Grantham J: Vasodilator factors in the systemic and local
adaptations to pregnancy. Reprod Biol Endocrinol 2009, 7:79.
28. Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion:
implications for the pathogenesis of intrauterine growth retardation and
preeclampsia. Biol Reprod 2003, 69:1–7.
29. Magness RR, Rosenfeld CR, Hassan A, Shaul PW: Endothelial vasodilator
production by uterine and systemic arteries. I. Effects of ANG II on PGI2
and NO in pregnancy. Am J Physiol 1996, 270:1914–1923.
30. Hemberger M: IFPA award in placentology lecture - characteristics and
significance of trophoblast giant cells. Placenta 2008, 29(Suppl A):4–9.
31. Anton L, Merrill DC, Neves LA, Brosnihan KB: Angiotensin-(1–7) inhibits
in vitro endothelial cell tube formation in human umbilical vein
endothelial cells through the AT(1–7) receptor. Endocrine 2007,
32:212–218.
32. Gallagher PE, Tallant EA: Inhibition of human lung cancer cell growth by
angiotensin-(1–7). Carcinogenesis 2004, 25:2045–2052.
33. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA: Angiotensin-(1–7)
inhibits tumor angiogenesis in human lung cancer xenografts with a
reduction in vascular endothelial growth factor. Mol Cancer Ther 2009,
8:1676–1683.
Valdés et al. Reproductive Biology and Endocrinology 2013, 11:5 Page 8 of 8
http://www.rbej.com/content/11/1/534. Machado RD, Santos RA, Andrade SP: Mechanisms of angiotensin-(1–7)-
induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol
2001, 280:R994–R1000.
35. Zhou L, Zhang R, Zhang L, Yao W, Li J, Yuan Y: Angiotensin-converting
enzyme 2 acts as a potential molecular target for pancreatic cancer
therapy. Cancer Lett 2011, 307:18–25.
doi:10.1186/1477-7827-11-5
Cite this article as: Valdés et al.: Utero-placental expression of
angiotensin-(1–7) and ACE2 in the pregnant guinea-pig. Reproductive
Biology and Endocrinology 2013 11:5.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
